Supplementary Figure S8 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian CarcinomaHelen Clark, Shannon N. Westin, Samira Aghlara-Fotovat et al.|Unknown|2026Cited by 0
Supplementary Figure S2 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian CarcinomaHelen Clark, Shannon N. Westin, Samira Aghlara-Fotovat et al.|Unknown|2026Cited by 0
Supplementary Figure S1 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian CarcinomaHelen Clark, Shannon N. Westin, Samira Aghlara-Fotovat et al.|Unknown|2026Cited by 0
Supplementary Figure S4 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian CarcinomaHelen Clark, Shannon N. Westin, Samira Aghlara-Fotovat et al.|Unknown|2026Cited by 0
Supplementary Data 1 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian CarcinomaHelen Clark, Shannon N. Westin, Samira Aghlara-Fotovat et al.|Unknown|2026Cited by 0